Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

TTP-054 demonstrates the ability to lower HbA1c in patients with type 2 diabetes

July 18, 2014

Researchers from Lexicon present promising data for LX-4211 in humans and mice

July 17, 2014

Merck & Co. synthesizes novel glucokinase activators

July 17, 2014

BioChaperone Combo shows promising PK/PD profile in early clinical trials

July 16, 2014

Treatment with PF-05231023 improves lipid parameters in patients with type 2 diabetes

July 16, 2014

G-Pen shows promising results in a phase II trial

July 15, 2014

Researchers at Merck & Co. prepare novel glucokinase activators

July 15, 2014

XMetA demonstrates efficacy in animal models of diabetes

July 15, 2014

New clinical data on remogliflozin etabonate presented

July 14, 2014

Pfizer studies PF-06743649 in new phase I program for gout

July 14, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...